|
General Information
|
|
|
Product
|
BTBD7 Antibody
|
|
Description
|
Affinity Purified BTB/POZ domain containing protein 7 Antibody
|
|
Verified Applications
|
CM, ELISA, ICC, IF, IHC, IP, WB
|
|
Species Cross Reactivity
|
Human, Mouse
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 1050-1150 on human BTBD7 protein.
|
|
Accession #
|
NCBI: NP_001002860
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.61-0.68 µg/µl in antibody stabilization buffer
|
|
Form
|
Affinity Purified
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
|
Confocal Microscopy
|
1:200
|
|
DB
|
1:10,000
|
|
ELISA
|
1:10,000
|
|
Immunocytochemistry
|
1:200
|
|
Immunohistochemistry
|
1:200
|
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:500
|
|
Protein
|
|
|
Uniprot #
|
Q9P203
|
|
Overview
|
Mediator of epithelial dynamics and organ branching by promoting cleft progression.
|
|
Molecular Function
|
Developmental proteins
|
|
Subcellular Location
|
Nucleus
|
|
Expression
|
Induced following accumulation of fibronectin in forming clefts, leading to local expression of the cell-scattering SNAIL2 and suppresion of E-cadherin levels.
|
|
Alternative Nomenclature
|
5730507E09Rik antibody
8030448M07 antibody
BTBD7 antibody
E130118E17Rik antibody
FUP1 antibody
|
BTB/POZ domain-containing protein 7 Antibody FITC
BTB/POZ domain-containing protein 7 Antibody BIOTIN
BTB/POZ domain-containing protein 7 Blocking Peptide
BTB/POZ domain-containing protein 7 Positive Control
